Schröder R, Kumar R, Patel M V. "一种3-甲基-2-噁唑烷酮的合成方法" [P]. US Patent, US 11938269 B2, 2025-12-07.
发明人张德明,罗永刚,唐晓军. "Method for the Synthesis of 19836-78-3
3-Methyloxazolidin-2-one
2-Oxazolidinone, 3-methyl-
4-27-00-02517 (Beilstein Handbook Reference)
BRN 0107744
EINECS 243-361-1
3-Methyl-2-oxazolidinone
3-Methyl-2-oxazolidone" [P]. 中国发明专利, 专利号 CN 116758271 B, 授权公告日 2021-01-22.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 3-甲基-2-噁唑烷酮 in Pharmaceutical Formulations". Molecules, 2023, 1175, 2662-2692.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-甲基-2-噁唑烷酮 as an Impurity". Anal. Chim. Acta, 2013, 495, (3), 2318-2343.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 19836-78-3
3-Methyloxazolidin-2-one
2-Oxazolidinone, 3-methyl-
4-27-00-02517 (Beilstein Handbook Reference)
BRN 0107744
EINECS 243-361-1
3-Methyl-2-oxazolidinone
3-Methyl-2-oxazolidone Using HRMS and NMR". J. Nat. Prod., 2011, 2203, 3483-3500.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 3-甲基-2-噁唑烷酮 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2021, 1196, (10), 6403-6425.